Brief: GeNeuro provides update on GNbAC1 multiple sclerosis clinical program

Geneuro SA

03/01/2017 16:46

Jan 3 (Reuters) - GeNeuro SA  GNRO.PA : 
    * GeNeuro provides update on GNbAC1 multiple sclerosis 
clinical program 
    * Enrollment completed for CHANGE-MS study ahead of 
schedule; 6-month top-line results now expected in early 4Q2017 
    * U.S. study in secondary progressive MS patients planned 
for 2H 2017 
    * ANGEL-MS study launched, dosing of first patient expected 
in April 2017 
 
Source text for Eikon:  ID:nBw9CdD35a  
Further company coverage:  GNRO.PA  
 
 ((Bangalore.newsroom@thomsonreuters.com;))